204-18: Shared Decision Making in Pharmacotherapy Management

4.39 (38 votes)

  • Registration Closed

204-18:  Shared Decision Making in Pharmacotherapy Management

Moving away from the old concepts of compliance or adherence, this presentation provides an insightful discussion of influences on a patients’ self-management of their illness. The participant will gain perspective on how providers can achieve a successful decision making partnership with their patient.


Presenter:
  Mary A. Gutierrez, PharmD, BCPP

Disclosures: The presenter and planners have no conflict of interest or commercial support to disclose. Off-label uses will be discussed during this presentation.


Session Length:
  1 hour 44 minutes

Target Audience:  RN, APRN


Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

  1. Identify factors that pose challenges for patients in effective self-management of medications.
  2. Identify strategies to avoid or minimize psychiatric medications' adverse drug effects and interactions.

Keywords: APRN Practice, Medication Management, Psychopharmacology


Continuing Nursing Education:
1.75 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


Originally Presented
APNA 16th Annual Clinical Psychopharmacology Institute
Baltimore, Maryland
Saturday June 9, 2018
1:45pm - 3:45pm

The contact hours for this session expire: January 1, 2022

Components visible upon registration.